225 related articles for article (PubMed ID: 34868337)
1. Identification of the Upregulation of MRPL13 as a Novel Prognostic Marker Associated with Overall Survival Time and Immunotherapy Response in Breast Cancer.
Ye H; Zhang N
Comput Math Methods Med; 2021; 2021():1498924. PubMed ID: 34868337
[TBL] [Abstract][Full Text] [Related]
2. Multi-omics analysis of MRPL-13 as a tumor-promoting marker from pan-cancer to lung adenocarcinoma.
Zhong X; He Z; Fan Y; Yin L; Hong Z; Tong Y; Bi Q; Zhu S
Aging (Albany NY); 2023 Oct; 15(19):10640-10680. PubMed ID: 37827692
[TBL] [Abstract][Full Text] [Related]
3. Identification of Five Immune-Related lncRNAs Predicting Survival and Tumor Microenvironment Characteristics in Breast Cancer.
Xiao R; Yang M; Tan Y; Ding R; Li D
Comput Math Methods Med; 2021; 2021():6676692. PubMed ID: 33727952
[TBL] [Abstract][Full Text] [Related]
4. Pan-Cancer Analysis of PARP1 Alterations as Biomarkers in the Prediction of Immunotherapeutic Effects and the Association of Its Expression Levels and Immunotherapy Signatures.
Zhang X; Wang Y; A G; Qu C; Chen J
Front Immunol; 2021; 12():721030. PubMed ID: 34531868
[TBL] [Abstract][Full Text] [Related]
5. Inhibiting KLRB1 expression is associated with impairing cancer immunity and leading to cancer progression and poor prognosis in breast invasive carcinoma patients.
He JR; Li D; Zhang QX; Liu T; Ding Y; Wu CY; Chen SS; Chen JL
Aging (Albany NY); 2023 Nov; 15(22):13265-13286. PubMed ID: 37988189
[TBL] [Abstract][Full Text] [Related]
6. Analysing a Novel RNA-Binding-Protein-Related Prognostic Signature Highly Expressed in Breast Cancer.
Lan Y; Su J; Xue Y; Zeng L; Cheng X; Zeng L
J Healthc Eng; 2021; 2021():9174055. PubMed ID: 34707800
[TBL] [Abstract][Full Text] [Related]
7. Identification and Prognostic Value Exploration of Cyclophosphamide (Cytoxan)-Centered Chemotherapy Response-Associated Genes in Breast Cancer.
Du J; Dong Y; Li Y
DNA Cell Biol; 2021 Nov; 40(11):1356-1368. PubMed ID: 34704810
[TBL] [Abstract][Full Text] [Related]
8. An eight-lncRNA signature predicts survival of breast cancer patients: a comprehensive study based on weighted gene co-expression network analysis and competing endogenous RNA network.
Sun M; Wu D; Zhou K; Li H; Gong X; Wei Q; Du M; Lei P; Zha J; Zhu H; Gu X; Huang D
Breast Cancer Res Treat; 2019 May; 175(1):59-75. PubMed ID: 30715658
[TBL] [Abstract][Full Text] [Related]
9. Subtype-specific risk models for accurately predicting the prognosis of breast cancer using differentially expressed autophagy-related genes.
Han B; Zhang H; Zhu Y; Han X; Wang Z; Gao Z; Yuan Y; Tian R; Zhang F; Niu R
Aging (Albany NY); 2020 Jul; 12(13):13318-13337. PubMed ID: 32649310
[TBL] [Abstract][Full Text] [Related]
10. MRPL13 Promotes Tumor Cell Proliferation, Migration and EMT Process in Breast Cancer Through the PI3K-AKT-mTOR Pathway.
Cai M; Li H; Chen R; Zhou X
Cancer Manag Res; 2021; 13():2009-2024. PubMed ID: 33658859
[TBL] [Abstract][Full Text] [Related]
11. Identification of Ten-Gene Related to Lipid Metabolism for Predicting Overall Survival of Breast Invasive Carcinoma.
Wang Z; Wang F
Contrast Media Mol Imaging; 2022; 2022():8348780. PubMed ID: 35919504
[TBL] [Abstract][Full Text] [Related]
12. Detecting prognostic biomarkers of breast cancer by regularized Cox proportional hazards models.
Li L; Liu ZP
J Transl Med; 2021 Dec; 19(1):514. PubMed ID: 34930307
[TBL] [Abstract][Full Text] [Related]
13. PCMT1 Is a Potential Prognostic Biomarker and Is Correlated with Immune Infiltrates in Breast Cancer.
Guo J; Du X; Li C
Biomed Res Int; 2022; 2022():4434887. PubMed ID: 35535040
[TBL] [Abstract][Full Text] [Related]
14. Systematic Analysis Uncovers Associations of PGK1 with Prognosis and Immunological Characteristics in Breast Cancer.
Li L; Bai Y; Gao Y; Li D; Chen L; Zhou C; Feng M; Chen X; Jin W; Cao Y
Dis Markers; 2021; 2021():7711151. PubMed ID: 34790279
[TBL] [Abstract][Full Text] [Related]
15. NR3C2-Related Transcriptome Profile and Clinical Outcome in Invasive Breast Carcinoma.
Lu J; Hu F; Zhou Y
Biomed Res Int; 2021; 2021():9025481. PubMed ID: 33564687
[TBL] [Abstract][Full Text] [Related]
16. ADRB1 was identified as a potential biomarker for breast cancer by the co-analysis of tumor mutational burden and immune infiltration.
Wang J; Zhang X; Li J; Ma X; Feng F; Liu L; Wu J; Sun C
Aging (Albany NY); 2020 Nov; 13(1):351-363. PubMed ID: 33234738
[TBL] [Abstract][Full Text] [Related]
17. Integrated pancancer analysis reveals the oncogene characteristics and prognostic value of DIP2B in breast cancer.
Song C; Shang F; Tu W; Liu X
BMC Cancer; 2023 Mar; 23(1):296. PubMed ID: 37004015
[TBL] [Abstract][Full Text] [Related]
18. Identification of LCN1 as a Potential Biomarker for Breast Cancer by Bioinformatic Analysis.
Yang Y; Li F; Luo X; Jia B; Zhao X; Liu B; Gao R; Yang L; Wei W; He J
DNA Cell Biol; 2019 Oct; 38(10):1088-1099. PubMed ID: 31424267
[TBL] [Abstract][Full Text] [Related]
19. Identification of a Three-RNA Binding Proteins (RBPs) Signature Predicting Prognosis for Breast Cancer.
Liu Y; Sun H; Li X; Liu Q; Zhao Y; Li L; Xu B; Hou Y; Jin W
Front Oncol; 2021; 11():663556. PubMed ID: 34322380
[TBL] [Abstract][Full Text] [Related]
20. Identification of the prognostic value of ferroptosis-related gene signature in breast cancer patients.
Wang D; Wei G; Ma J; Cheng S; Jia L; Song X; Zhang M; Ju M; Wang L; Zhao L; Xin S
BMC Cancer; 2021 May; 21(1):645. PubMed ID: 34059009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]